PHARMA NORD NORGE AS

3048 DRAMMEN

Finances

Share Ownership

Return on Equity

71,53 %

Current Ratio

0,97

Debt-to-Equity Ratio

0,12

Key figures (NOK)	2022	2021	2020	2019
Revenue	35 518 000	42 362 000	38 558 000	25 646 000
Net Income	799 000	920 000	837 000	571 000
Total Assets	18 263 000	20 497 000	17 487 000	13 821 000
Total Equity	1 117 000	1 318 000	1 697 000	1 460 000

Income (NOK)	2022	2021	2020	2019
Revenue	35 518 000	42 362 000	38 558 000	25 646 000
Expenditure	34 466 000	41 150 000	37 449 000	24 887 000
Operating Profit	1 052 000	1 213 000	1 109 000	759 000
Financial Income	1 000	0	1 000	1 000
Financial Costs	25 000	32 000	34 000	26 000
Financial Balance	−24 000	−32 000	−33 000	−25 000
Earnings Before Tax	1 028 000	1 181 000	1 076 000	733 000
Tax	228 000	261 000	238 000	162 000
Net Income	799 000	920 000	837 000	571 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 791 000	1 901 000	2 008 000	2 025 000
Total Current Assets	16 471 000	18 596 000	15 479 000	11 796 000
Total Assets	18 263 000	20 497 000	17 487 000	13 821 000
Total Retained Equity	117 000	318 000	697 000	460 000
Total Equity	1 117 000	1 318 000	1 697 000	1 460 000
Total Long-Term Debt	133 000	142 000	149 000	148 000
Total Current Debt	17 013 000	19 038 000	15 641 000	12 214 000
Total Equity and Debt	18 263 000	20 497 000	17 487 000	13 821 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	35 260 000	39 160 000	34 358 000	19 840 000
Other Income	257 000	3 202 000	4 200 000	5 806 000
Revenue	35 518 000	42 362 000	38 558 000	25 646 000
Cost of Goods Sold	24 133 000	31 096 000	27 385 000	16 295 000
Salary Costs	3 880 000	3 367 000	3 243 000	3 265 000
Depreciation	110 000	107 000	103 000	91 000
Impairment	0	0	0	0
Expenditure	34 466 000	41 150 000	37 449 000	24 887 000
Operating Profit	1 052 000	1 213 000	1 109 000	759 000
Financial Income	1 000	0	1 000	1 000
Financial Costs	25 000	32 000	34 000	26 000
Financial Balance	−24 000	−32 000	−33 000	−25 000
Dividends	1 000 000	1 300 000	600 000	500 000
Net Income	799 000	920 000	837 000	571 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	1 756 000	1 846 000	1 936 000	2 025 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	35 000	55 000	72 000	0
Total Tangible Assets	1 791 000	1 901 000	2 008 000	2 025 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	1 791 000	1 901 000	2 008 000	2 025 000
Stock	8 055 000	7 918 000	5 854 000	6 666 000
Total Investments	0	0	0	0
Cash, Bank	3 370 000	3 899 000	3 239 000	2 805 000
Total Current Assets	16 471 000	18 596 000	15 479 000	11 796 000
Total Assets	18 263 000	20 497 000	17 487 000	13 821 000
Total Equity	1 117 000	1 318 000	1 697 000	1 460 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	133 000	142 000	149 000	148 000
Creditors	14 469 000	15 798 000	13 401 000	10 620 000
Unpaid Taxes	737 000	1 033 000	955 000	555 000
Dividends	1 000 000	1 300 000	600 000	500 000
Other Current Debt	1 569 000	1 939 000	1 048 000	876 000
Total Current Debt	17 013 000	19 038 000	15 641 000	12 214 000
Total Equity and Debt	18 263 000	20 497 000	17 487 000	13 821 000

Financial indicators	2022	2021	2020	2019
Return on Equity	71,53 %	69,8 %	49,32 %	39,11 %
Debt-to-Equity Ratio	0,12	0,11	0,09	0,1
Operating Profit Margin	2,96 %	2,86 %	2,88 %	2,96 %
Current Ratio	0,97	0,98	0,99	0,97
Quick Ratio	1,84	1,67	1,58	2,13
Equity Ratio	0,06	0,06	0,1	0,11
Gross Profit Margin	32,05 %	26,59 %	28,98 %	36,46 %